Abstract
Yersinia pseudotuberculosis is an enteric pathogen that causes a variety of clinical symptoms in the human. Recently, we reported the production of a superantigen (Y. pseudotuberculosis-derived mitogen, YPM) by this organism and characterized the gene structure of ypm. To further study the potential pathogenic role of YPM in Y. pseudotuberculosis infection, we assayed IgG anti-YPM antibodies and T cell antigen receptor-Vbeta expression of the T cells in peripheral blood and in mesenteric lymph node in patients acutely infected with Y. pseudotuberculosis. 20 out of 33 patients (61%) had an elevated antibody titer compared with healthy controls (P = 0.0001). Patients with systemic symptoms such as lymphadenopathy, transient renal dysfunction, and arthritis had significantly higher titers of anti-YPM than patients with gastrointestinal tract symptoms alone. T cells bearing the Vbeta3 gene segment were significantly increased (P = 0.009) among acute phase patients compared with healthy children. During the convalescence phase of the illness, there was a reduction in the abnormal level of Vbeta3 T cells. Moreover, in the mesenteric lymph node, an elevated level of Vbeta3 T cells compared with peripheral blood and a sequence diversity in the junctional region of the T cell antigen receptor beta-chain containing Vbeta3 element was observed in one patient. Together, these findings suggest that YPM was produced in vivo and played an important role in the pathogenesis of Y. pseudotuberculosis infection.
Full Text
The Full Text of this article is available as a PDF (292.9 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Abe J., Takeda T., Watanabe Y., Nakao H., Kobayashi N., Leung D. Y., Kohsaka T. Evidence for superantigen production by Yersinia pseudotuberculosis. J Immunol. 1993 Oct 15;151(8):4183–4188. [PubMed] [Google Scholar]
- Autenrieth I. B., Beer M., Bohn E., Kaufmann S. H., Heesemann J. Immune responses to Yersinia enterocolitica in susceptible BALB/c and resistant C57BL/6 mice: an essential role for gamma interferon. Infect Immun. 1994 Jun;62(6):2590–2599. doi: 10.1128/iai.62.6.2590-2599.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Autenrieth I. B., Vogel U., Preger S., Heymer B., Heesemann J. Experimental Yersinia enterocolitica infection in euthymic and T-cell-deficient athymic nude C57BL/6 mice: comparison of time course, histomorphology, and immune response. Infect Immun. 1993 Jun;61(6):2585–2595. doi: 10.1128/iai.61.6.2585-2595.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Baba K., Takeda N., Tanaka M. Cases of Yersinia pseudotuberculosis infection having diagnostic criteria of Kawasaki disease. Contrib Microbiol Immunol. 1991;12:292–296. [PubMed] [Google Scholar]
- Balk S. P., Ebert E. C., Blumenthal R. L., McDermott F. V., Wucherpfennig K. W., Landau S. B., Blumberg R. S. Oligoclonal expansion and CD1 recognition by human intestinal intraepithelial lymphocytes. Science. 1991 Sep 20;253(5026):1411–1415. doi: 10.1126/science.1716785. [DOI] [PubMed] [Google Scholar]
- Blaser M. J., Miller R. A., Lacher J., Singleton J. W. Patients with active Crohn's disease have elevated serum antibodies to antigens of seven enteric bacterial pathogens. Gastroenterology. 1984 Oct;87(4):888–894. [PubMed] [Google Scholar]
- Bliska J. B., Guan K. L., Dixon J. E., Falkow S. Tyrosine phosphate hydrolysis of host proteins by an essential Yersinia virulence determinant. Proc Natl Acad Sci U S A. 1991 Feb 15;88(4):1187–1191. doi: 10.1073/pnas.88.4.1187. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Blumberg R. S., Yockey C. E., Gross G. G., Ebert E. C., Balk S. P. Human intestinal intraepithelial lymphocytes are derived from a limited number of T cell clones that utilize multiple V beta T cell receptor genes. J Immunol. 1993 Jun 1;150(11):5144–5153. [PubMed] [Google Scholar]
- Bohach G. A., Fast D. J., Nelson R. D., Schlievert P. M. Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses. Crit Rev Microbiol. 1990;17(4):251–272. doi: 10.3109/10408419009105728. [DOI] [PubMed] [Google Scholar]
- Brubaker R. R. Factors promoting acute and chronic diseases caused by yersiniae. Clin Microbiol Rev. 1991 Jul;4(3):309–324. doi: 10.1128/cmr.4.3.309. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bölin I., Wolf-Watz H. The plasmid-encoded Yop2b protein of Yersinia pseudotuberculosis is a virulence determinant regulated by calcium and temperature at the level of transcription. Mol Microbiol. 1988 Mar;2(2):237–245. doi: 10.1111/j.1365-2958.1988.tb00025.x. [DOI] [PubMed] [Google Scholar]
- Carniel E., Mollaret H. H. Yersiniosis. Comp Immunol Microbiol Infect Dis. 1990;13(2):51–58. doi: 10.1016/0147-9571(90)90516-v. [DOI] [PubMed] [Google Scholar]
- Choi Y. W., Kotzin B., Herron L., Callahan J., Marrack P., Kappler J. Interaction of Staphylococcus aureus toxin "superantigens" with human T cells. Proc Natl Acad Sci U S A. 1989 Nov;86(22):8941–8945. doi: 10.1073/pnas.86.22.8941. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Choi Y., Lafferty J. A., Clements J. R., Todd J. K., Gelfand E. W., Kappler J., Marrack P., Kotzin B. L. Selective expansion of T cells expressing V beta 2 in toxic shock syndrome. J Exp Med. 1990 Sep 1;172(3):981–984. doi: 10.1084/jem.172.3.981. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cornelis G., Laroche Y., Balligand G., Sory M. P., Wauters G. Yersinia enterocolitica, a primary model for bacterial invasiveness. Rev Infect Dis. 1987 Jan-Feb;9(1):64–87. doi: 10.1093/clinids/9.1.64. [DOI] [PubMed] [Google Scholar]
- Davenport A., O'Connor B., Finn R. Acute renal failure following Yersinia pseudotuberculosis septicaemia. Postgrad Med J. 1987 Sep;63(743):815–816. doi: 10.1136/pgmj.63.743.815. [DOI] [PMC free article] [PubMed] [Google Scholar]
- El-Maraghi N. R., Mair N. S. The histopathology of enteric infection with Yersinia pseudotuberculosis. Am J Clin Pathol. 1979 Jun;71(6):631–639. doi: 10.1093/ajcp/71.6.631. [DOI] [PubMed] [Google Scholar]
- Fleischer B. A conserved mechanism of T lymphocyte stimulation by microbial exotoxins. Microb Pathog. 1989 Aug;7(2):79–83. doi: 10.1016/0882-4010(89)90027-2. [DOI] [PubMed] [Google Scholar]
- Granfors K., Jalkanen S., von Essen R., Lahesmaa-Rantala R., Isomäki O., Pekkola-Heino K., Merilahti-Palo R., Saario R., Isomäki H., Toivanen A. Yersinia antigens in synovial-fluid cells from patients with reactive arthritis. N Engl J Med. 1989 Jan 26;320(4):216–221. doi: 10.1056/NEJM198901263200404. [DOI] [PubMed] [Google Scholar]
- Gross G. G., Schwartz V. L., Stevens C., Ebert E. C., Blumberg R. S., Balk S. P. Distribution of dominant T cell receptor beta chains in human intestinal mucosa. J Exp Med. 1994 Oct 1;180(4):1337–1344. doi: 10.1084/jem.180.4.1337. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hammer M., Zeidler H., Klimsa S., Heesemann J. Yersinia enterocolitica in the synovial membrane of patients with Yersinia-induced arthritis. Arthritis Rheum. 1990 Dec;33(12):1795–1800. doi: 10.1002/art.1780331206. [DOI] [PubMed] [Google Scholar]
- Hermann E., Lohse A. W., Van der Zee R., Van Eden W., Mayet W. J., Probst P., Poralla T., Meyer zum Büschenfelde K. H., Fleischer B. Synovial fluid-derived Yersinia-reactive T cells responding to human 65-kDa heat-shock protein and heat-stressed antigen-presenting cells. Eur J Immunol. 1991 Sep;21(9):2139–2143. doi: 10.1002/eji.1830210923. [DOI] [PubMed] [Google Scholar]
- Hermann E., Yu D. T., Meyer zum Büschenfelde K. H., Fleischer B. HLA-B27-restricted CD8 T cells derived from synovial fluids of patients with reactive arthritis and ankylosing spondylitis. Lancet. 1993 Sep 11;342(8872):646–650. doi: 10.1016/0140-6736(93)91760-j. [DOI] [PubMed] [Google Scholar]
- Inoue M., Nakashima H., Ueba O., Ishida T., Date H., Kobashi S., Takagi K., Nishu T., Tsubokura M. Community outbreak of Yersinia pseudotuberculosis. Microbiol Immunol. 1984;28(8):883–891. doi: 10.1111/j.1348-0421.1984.tb00744.x. [DOI] [PubMed] [Google Scholar]
- Isberg R. R., Falkow S. A single genetic locus encoded by Yersinia pseudotuberculosis permits invasion of cultured animal cells by Escherichia coli K-12. Nature. 1985 Sep 19;317(6034):262–264. doi: 10.1038/317262a0. [DOI] [PubMed] [Google Scholar]
- Ito Y., Abe J., Yoshino K., Takeda T., Kohsaka T. Sequence analysis of the gene for a novel superantigen produced by Yersinia pseudotuberculosis and expression of the recombinant protein. J Immunol. 1995 Jun 1;154(11):5896–5906. [PubMed] [Google Scholar]
- Jardetzky T. S., Brown J. H., Gorga J. C., Stern L. J., Urban R. G., Chi Y. I., Stauffacher C., Strominger J. L., Wiley D. C. Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen. Nature. 1994 Apr 21;368(6473):711–718. doi: 10.1038/368711a0. [DOI] [PubMed] [Google Scholar]
- KNAPP W. Mesenteric adenitis due to Pasteurella pseudotuberculosis in young people. N Engl J Med. 1958 Oct 16;259(16):776–778. doi: 10.1056/NEJM195810162591606. [DOI] [PubMed] [Google Scholar]
- Kappler J., Kotzin B., Herron L., Gelfand E. W., Bigler R. D., Boylston A., Carrel S., Posnett D. N., Choi Y., Marrack P. V beta-specific stimulation of human T cells by staphylococcal toxins. Science. 1989 May 19;244(4906):811–813. doi: 10.1126/science.2524876. [DOI] [PubMed] [Google Scholar]
- Kawabe Y., Ochi A. Programmed cell death and extrathymic reduction of Vbeta8+ CD4+ T cells in mice tolerant to Staphylococcus aureus enterotoxin B. Nature. 1991 Jan 17;349(6306):245–248. doi: 10.1038/349245a0. [DOI] [PubMed] [Google Scholar]
- Kotb M. Bacterial pyrogenic exotoxins as superantigens. Clin Microbiol Rev. 1995 Jul;8(3):411–426. doi: 10.1128/cmr.8.3.411. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kotzin B. L., Leung D. Y., Kappler J., Marrack P. Superantigens and their potential role in human disease. Adv Immunol. 1993;54:99–166. doi: 10.1016/s0065-2776(08)60534-9. [DOI] [PubMed] [Google Scholar]
- Krober M. S., Bass J. W., Barcia P. J. Scarlatiniform rash and pleural effusion in a patient with Yersinia pseudotuberculosis infection. J Pediatr. 1983 Jun;102(6):879–881. doi: 10.1016/s0022-3476(83)80016-x. [DOI] [PubMed] [Google Scholar]
- Lahesmaa R., Yssel H., Batsford S., Luukkainen R., Möttönen T., Steinman L., Peltz G. Yersinia enterocolitica activates a T helper type 1-like T cell subset in reactive arthritis. J Immunol. 1992 May 15;148(10):3079–3085. [PubMed] [Google Scholar]
- Leino R., Mäkelä A. L., Tiilikainen A., Toivanen A. Yersinia arthritis in children. Scand J Rheumatol. 1980;9(4):245–249. doi: 10.3109/03009748009112357. [DOI] [PubMed] [Google Scholar]
- Leung D. Y., Harbeck R., Bina P., Reiser R. F., Yang E., Norris D. A., Hanifin J. M., Sampson H. A. Presence of IgE antibodies to staphylococcal exotoxins on the skin of patients with atopic dermatitis. Evidence for a new group of allergens. J Clin Invest. 1993 Sep;92(3):1374–1380. doi: 10.1172/JCI116711. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Life P. F., Viner N. J., Bacon P. A., Gaston J. S. Synovial fluid antigen-presenting cells unmask peripheral blood T cell responses to bacterial antigens in inflammatory arthritis. Clin Exp Immunol. 1990 Feb;79(2):189–194. doi: 10.1111/j.1365-2249.1990.tb05177.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Maina C. V., Riggs P. D., Grandea A. G., 3rd, Slatko B. E., Moran L. S., Tagliamonte J. A., McReynolds L. A., Guan C. D. An Escherichia coli vector to express and purify foreign proteins by fusion to and separation from maltose-binding protein. Gene. 1988 Dec 30;74(2):365–373. doi: 10.1016/0378-1119(88)90170-9. [DOI] [PubMed] [Google Scholar]
- Marrack P., Kappler J. The staphylococcal enterotoxins and their relatives. Science. 1990 May 11;248(4956):705–711. doi: 10.1126/science.2185544. [DOI] [PubMed] [Google Scholar]
- McCormack J. E., Callahan J. E., Kappler J., Marrack P. C. Profound deletion of mature T cells in vivo by chronic exposure to exogenous superantigen. J Immunol. 1993 May 1;150(9):3785–3792. [PubMed] [Google Scholar]
- Miethke T., Wahl C., Regele D., Gaus H., Heeg K., Wagner H. Superantigen mediated shock: a cytokine release syndrome. Immunobiology. 1993 Nov;189(3-4):270–284. doi: 10.1016/S0171-2985(11)80362-1. [DOI] [PubMed] [Google Scholar]
- Noll A., Roggenkamp A., Heesemann J., Autenrieth I. B. Protective role for heat shock protein-reactive alpha beta T cells in murine yersiniosis. Infect Immun. 1994 Jul;62(7):2784–2791. doi: 10.1128/iai.62.7.2784-2791.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
- O'Hehir R. E., Lamb J. R. Induction of specific clonal anergy in human T lymphocytes by Staphylococcus aureus enterotoxins. Proc Natl Acad Sci U S A. 1990 Nov;87(22):8884–8888. doi: 10.1073/pnas.87.22.8884. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Probst P., Hermann E., Meyer zum Büschenfelde K. H., Fleischer B. Multiclonal synovial T cell response to Yersinia enterocolitica in reactive arthritis: the Yersinia 61-kDa heat-shock protein is not the major target antigen. J Infect Dis. 1993 Feb;167(2):385–391. doi: 10.1093/infdis/167.2.385. [DOI] [PubMed] [Google Scholar]
- Robinson M. A. The human T cell receptor beta-chain gene complex contains at least 57 variable gene segments. Identification of six V beta genes in four new gene families. J Immunol. 1991 Jun 15;146(12):4392–4397. [PubMed] [Google Scholar]
- Rosqvist R., Forsberg A., Rimpiläinen M., Bergman T., Wolf-Watz H. The cytotoxic protein YopE of Yersinia obstructs the primary host defence. Mol Microbiol. 1990 Apr;4(4):657–667. doi: 10.1111/j.1365-2958.1990.tb00635.x. [DOI] [PubMed] [Google Scholar]
- Rosqvist R., Magnusson K. E., Wolf-Watz H. Target cell contact triggers expression and polarized transfer of Yersinia YopE cytotoxin into mammalian cells. EMBO J. 1994 Feb 15;13(4):964–972. doi: 10.1002/j.1460-2075.1994.tb06341.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Saari K. M., Mäki M., Päivönsalo T., Leino R., Toivanen A. Acute anterior uveitis and conjunctivitis following Yersinia infection in children. Int Ophthalmol. 1986 Dec;9(4):237–241. doi: 10.1007/BF00137536. [DOI] [PubMed] [Google Scholar]
- Sato K., Ouchi K., Taki M. Yersinia pseudotuberculosis infection in children, resembling Izumi fever and Kawasaki syndrome. Pediatr Infect Dis. 1983 Mar-Apr;2(2):123–126. doi: 10.1097/00006454-198303000-00011. [DOI] [PubMed] [Google Scholar]
- Starnbach M. N., Bevan M. J. Cells infected with Yersinia present an epitope to class I MHC-restricted CTL. J Immunol. 1994 Aug 15;153(4):1603–1612. [PMC free article] [PubMed] [Google Scholar]
- Takei S., Arora Y. K., Walker S. M. Intravenous immunoglobulin contains specific antibodies inhibitory to activation of T cells by staphylococcal toxin superantigens [see comment]. J Clin Invest. 1993 Feb;91(2):602–607. doi: 10.1172/JCI116240. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tertti R., Granfors K., Lehtonen O. P., Mertsola J., Mäkelä A. L., Välimäki I., Hänninen P., Toivanen A. An outbreak of Yersinia pseudotuberculosis infection. J Infect Dis. 1984 Feb;149(2):245–250. doi: 10.1093/infdis/149.2.245. [DOI] [PubMed] [Google Scholar]
- Treacher D. F., Jewell D. P. Yersinia colitis associated with Crohn's disease. Postgrad Med J. 1985 Feb;61(712):173–174. doi: 10.1136/pgmj.61.712.173. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Uchiyama T., Miyoshi-Akiyama T., Kato H., Fujimaki W., Imanishi K., Yan X. J. Superantigenic properties of a novel mitogenic substance produced by Yersinia pseudotuberculosis isolated from patients manifesting acute and systemic symptoms. J Immunol. 1993 Oct 15;151(8):4407–4413. [PubMed] [Google Scholar]
- Une T. Studies on the pathogenicity of Yersinia enterocolitica. III. Comparative studies between Y. enterocolitica and Y. pseudotuberculosis. Microbiol Immunol. 1977;21(9):505–516. doi: 10.1111/j.1348-0421.1977.tb00316.x. [DOI] [PubMed] [Google Scholar]
- Van Kerckhove C., Russell G. J., Deusch K., Reich K., Bhan A. K., DerSimonian H., Brenner M. B. Oligoclonality of human intestinal intraepithelial T cells. J Exp Med. 1992 Jan 1;175(1):57–63. doi: 10.1084/jem.175.1.57. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wahl C., Miethke T., Heeg K., Wagner H. Clonal deletion as direct consequence of an in vivo T cell response to bacterial superantigen. Eur J Immunol. 1993 May;23(5):1197–1200. doi: 10.1002/eji.1830230536. [DOI] [PubMed] [Google Scholar]
- Watanabe-Ohnishi R., Low D. E., McGeer A., Stevens D. L., Schlievert P. M., Newton D., Schwartz B., Kreiswirth B., Kotb M. Selective depletion of V beta-bearing T cells in patients with severe invasive group A streptococcal infections and streptococcal toxic shock syndrome. Ontario Streptococcal Study Project. J Infect Dis. 1995 Jan;171(1):74–84. doi: 10.1093/infdis/171.1.74. [DOI] [PubMed] [Google Scholar]
- White J., Herman A., Pullen A. M., Kubo R., Kappler J. W., Marrack P. The V beta-specific superantigen staphylococcal enterotoxin B: stimulation of mature T cells and clonal deletion in neonatal mice. Cell. 1989 Jan 13;56(1):27–35. doi: 10.1016/0092-8674(89)90980-x. [DOI] [PubMed] [Google Scholar]
- Winblad S., Niléhn B., Sternby N. H. Yersinia enterocolitica (Pasteurella x) in human enteric infections. Br Med J. 1966 Dec 3;2(5526):1363–1366. doi: 10.1136/bmj.2.5526.1363. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yoshino K., Ramamurthy T., Nair G. B., Fukushima H., Ohtomo Y., Takeda N., Kaneko S., Takeda T. Geographical heterogeneity between Far East and Europe in prevalence of ypm gene encoding the novel superantigen among Yersinia pseudotuberculosis strains. J Clin Microbiol. 1995 Dec;33(12):3356–3358. doi: 10.1128/jcm.33.12.3356-3358.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]